49 related articles for article (PubMed ID: 26551707)
21. Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation.
Arenas Valencia C; Lopez Kleine L; Pinzon Velasco AM; Cardona Barreto AY; Arteaga Diaz CE
Fam Cancer; 2018 Oct; 17(4):587-599. PubMed ID: 29302811
[TBL] [Abstract][Full Text] [Related]
22. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
[TBL] [Abstract][Full Text] [Related]
23. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K
Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700
[TBL] [Abstract][Full Text] [Related]
24. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
25. Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1).
Sandhu IS; Maksim NJ; Amouzougan EA; Gallion BW; Raviele AL; Ooi A
Biochem Soc Trans; 2015 Aug; 43(4):650-6. PubMed ID: 26551707
[TBL] [Abstract][Full Text] [Related]
26. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
Ooi A; Furge KA
Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
[TBL] [Abstract][Full Text] [Related]
27. [From gene to disease; cutaneous leiomyomatosis].
Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
[TBL] [Abstract][Full Text] [Related]
28. Hereditary leiomyomatosis and renal cell cancer (HLRCC).
Kiuru M; Launonen V
Curr Mol Med; 2004 Dec; 4(8):869-75. PubMed ID: 15579034
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
Sudarshan S; Pinto PA; Neckers L; Linehan WM
Nat Clin Pract Urol; 2007 Feb; 4(2):104-10. PubMed ID: 17287871
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
Badeloe S; Frank J
Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
[TBL] [Abstract][Full Text] [Related]
31. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma.
Skala SL; Dhanasekaran SM; Mehra R
Arch Pathol Lab Med; 2018 Oct; 142(10):1202-1215. PubMed ID: 30281371
[TBL] [Abstract][Full Text] [Related]
32. Hereditary leiomyomatosis and renal cell cancer syndrome: An update and review.
Patel VM; Handler MZ; Schwartz RA; Lambert WC
J Am Acad Dermatol; 2017 Jul; 77(1):149-158. PubMed ID: 28314682
[TBL] [Abstract][Full Text] [Related]
33. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
Alam NA; Olpin S; Leigh IM
Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
[TBL] [Abstract][Full Text] [Related]
34. Molecular Aspects of the FAH Mutations Involved in HT1 Disease.
Morrow G; Angileri F; Tanguay RM
Adv Exp Med Biol; 2017; 959():25-48. PubMed ID: 28755182
[TBL] [Abstract][Full Text] [Related]
35. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]